CareMax, Inc.
CareMax, Inc. (CMAX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cmax · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for CareMax, Inc. (CMAX) measures how much investors pay for each dollar of the company's trailing earnings. CMAX's current PE ratio of N/A is calculated by dividing its stock price of $0.42 by its TTM earnings per share of -$183.30.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2018 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
Historical PE Range
Past 3 fiscal years · Front-end computedMinQ1 · 25%28.5x
MedianQ3 · 75%31.1x
Max
At N/A, CMAX's current P/E is lower than in 0% of its annual fiscal year readings over the past 3 years — historically low.
Percentile calculated from annual fiscal year data points, not by trading day. Years where PE ≤ 0 or > 9,999 are excluded.
PE Ratio vs Peers
Medical - Healthcare Information Services · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
CareMax, Inc.You CMAX | $2M | N/A | — | -$183.30 |
 ASLAN Pharmaceuticals Limited ASLN | $777M | N/A | — | -$10.75 |
 Avinger, Inc. AVGR | $2M | N/A | — | -$23.31 |
 IMAC Holdings, Inc. BACK | $0M | N/A | — | -$5.76 |
 G Medical Innovations Holdings Ltd GMVD | $2M | N/A | — | $0.00 |
 MSP Recovery, Inc. MSPR | $0M | N/A | — | -$359.78 |
 NAYA Biosciences, Inc. NAYA | $1M | N/A | — | -$29.39 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | — | $-183.30 | — | |
2022-12-31 FY2022 | — | $-12.49 | — | |
2021-12-31 FY2021 | — | $-3.90 | — | |
2020-12-31 FY2020 | 28.51x | $16.42 | +58.9% | |
2019-12-31 FY2019 | 17.95x | $16.55 | -42.4% | |
2018-12-31 FY2018 | 31.13x | $9.54 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for CareMax, Inc. (CMAX) measures how much investors pay for each dollar of the company's trailing earnings. CMAX's current PE ratio of N/A is calculated by dividing its stock price of $0.42 by its TTM earnings per share of -$183.30.
Frequently asked questions
CMAX pe ratio · 6 questionsCMAX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.42 and TTM EPS of -$183.30. Data sourced from Financial Modeling Prep via CMAX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · CareMax, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09